BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 30377265)

  • 1. KDM3A histone demethylase functions as an essential factor for activation of JAK2-STAT3 signaling pathway.
    Kim H; Kim D; Choi SA; Kim CR; Oh SK; Pyo KE; Kim J; Lee SH; Yoon JB; Zhang Y; Baek SH
    Proc Natl Acad Sci U S A; 2018 Nov; 115(46):11766-11771. PubMed ID: 30377265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The histone demethylase KDM3A regulates the transcriptional program of the androgen receptor in prostate cancer cells.
    Wilson S; Fan L; Sahgal N; Qi J; Filipp FV
    Oncotarget; 2017 May; 8(18):30328-30343. PubMed ID: 28416760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of histone demethylase KDM3A-dependent AP-1 transactivity on hepatotumorigenesis induced by PI3K activation.
    Nakatsuka T; Tateishi K; Kudo Y; Yamamoto K; Nakagawa H; Fujiwara H; Takahashi R; Miyabayashi K; Asaoka Y; Tanaka Y; Ijichi H; Hirata Y; Otsuka M; Kato M; Sakai J; Tachibana M; Aburatani H; Shinkai Y; Koike K
    Oncogene; 2017 Nov; 36(45):6262-6271. PubMed ID: 28692045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone demethylase KDM3a, a novel regulator of vascular smooth muscle cells, controls vascular neointimal hyperplasia in diabetic rats.
    Chen J; Zhang J; Yang J; Xu L; Hu Q; Xu C; Yang S; Jiang H
    Atherosclerosis; 2017 Feb; 257():152-163. PubMed ID: 28135625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ACK1 tyrosine kinase interacts with histone demethylase KDM3A to regulate the mammary tumor oncogene HOXA1.
    Mahajan K; Lawrence HR; Lawrence NJ; Mahajan NP
    J Biol Chem; 2014 Oct; 289(41):28179-91. PubMed ID: 25148682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of metastatic potential by TrkB via activation of IL6/JAK2/STAT3 and PI3K/AKT signaling in breast cancer.
    Kim MS; Lee WS; Jeong J; Kim SJ; Jin W
    Oncotarget; 2015 Nov; 6(37):40158-71. PubMed ID: 26515594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia inducible factor-3α promotes osteosarcoma progression by activating KDM3A-mediated demethylation of SOX9.
    Li ZF; Meng DD; Liu YY; Bi FG; Tian K; Xu JZ; Sun JG; Gu CX; Li Y
    Chem Biol Interact; 2022 Jan; 351():109759. PubMed ID: 34826399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-6 and sIL-6R induces STAT3-dependent differentiation of human VSMCs into osteoblast-like cells through JMJD2B-mediated histone demethylation of RUNX2.
    Kurozumi A; Nakano K; Yamagata K; Okada Y; Nakayamada S; Tanaka Y
    Bone; 2019 Jul; 124():53-61. PubMed ID: 30981888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Janus kinase-signal transducer and activator of transcription mediates phosphatidic acid-induced interleukin (IL)-1beta and IL-6 production.
    Lee C; Lim HK; Sakong J; Lee YS; Kim JR; Baek SH
    Mol Pharmacol; 2006 Mar; 69(3):1041-7. PubMed ID: 16354768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of a pro-survival pathway IL-6/JAK2/STAT3 contributes to glial fibrillary acidic protein induction during the cholera toxin-induced differentiation of C6 malignant glioma cells.
    Shu M; Zhou Y; Zhu W; Wu S; Zheng X; Yan G
    Mol Oncol; 2011 Jun; 5(3):265-72. PubMed ID: 21470923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific phosphorylation of histone demethylase KDM3A determines target gene expression in response to heat shock.
    Cheng MB; Zhang Y; Cao CY; Zhang WL; Zhang Y; Shen YF
    PLoS Biol; 2014 Dec; 12(12):e1002026. PubMed ID: 25535969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. cAMP/PKA enhances interleukin-1β-induced interleukin-6 synthesis through STAT3 in glial cells.
    Tanabe K; Kozawa O; Iida H
    Cell Signal; 2016 Jan; 28(1):19-24. PubMed ID: 26527061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysine demethylase KDM3A regulates breast cancer cell invasion and apoptosis by targeting histone and the non-histone protein p53.
    Ramadoss S; Guo G; Wang CY
    Oncogene; 2017 Jan; 36(1):47-59. PubMed ID: 27270439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trichostatin A, a histone deacetylase inhibitor, suppresses JAK2/STAT3 signaling via inducing the promoter-associated histone acetylation of SOCS1 and SOCS3 in human colorectal cancer cells.
    Xiong H; Du W; Zhang YJ; Hong J; Su WY; Tang JT; Wang YC; Lu R; Fang JY
    Mol Carcinog; 2012 Feb; 51(2):174-84. PubMed ID: 21520296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KDM3A-mediated demethylation of histone H3 lysine 9 facilitates the chromatin binding of Neurog2 during neurogenesis.
    Lin H; Zhu X; Chen G; Song L; Gao L; Khand AA; Chen Y; Lin G; Tao Q
    Development; 2017 Oct; 144(20):3674-3685. PubMed ID: 29042477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II activates JAK2/STAT3 pathway and induces interleukin-6 production in cultured rat brainstem astrocytes.
    Kandalam U; Clark MA
    Regul Pept; 2010 Jan; 159(1-3):110-6. PubMed ID: 19748527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3-Deoxy-2β,16-dihydroxynagilactone E, a natural compound from Podocarpus nagi, preferentially inhibits JAK2/STAT3 signaling by allosterically interacting with the regulatory domain of JAK2 and induces apoptosis of cancer cells.
    Shan H; Yao S; Ye Y; Yu Q
    Acta Pharmacol Sin; 2019 Dec; 40(12):1578-1586. PubMed ID: 31201357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-6 attenuates trimethyltin-induced cognitive dysfunction via activation of JAK2/STAT3, M1 mAChR and ERK signaling network.
    Kim BK; Tran HY; Shin EJ; Lee C; Chung YH; Jeong JH; Bach JH; Kim WK; Park DH; Saito K; Nabeshima T; Kim HC
    Cell Signal; 2013 Jun; 25(6):1348-60. PubMed ID: 23499905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the IL-6/JAK2/STAT3 pathway induces plasma cell mastitis in mice.
    Liu Y; Zhang J; Zhou YH; Zhang HM; Wang K; Ren Y; Jiang YN; Han SP; He JJ; Tang XJ
    Cytokine; 2018 Oct; 110():150-158. PubMed ID: 29751177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sesquiterpene dimmer (DSF-27) inhibits the release of neuroinflammatory mediators from microglia by targeting spleen tyrosine kinase (Syk) and Janus kinase 2 (Jak2): Two major non-receptor tyrosine signaling proteins involved in inflammatory events.
    Zeng KW; Wang S; Dong X; Jiang Y; Jin HW; Tu PF
    Toxicol Appl Pharmacol; 2014 Mar; 275(3):244-56. PubMed ID: 24486434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.